Literature DB >> 20626905

Late presenters to HIV care and treatment, identification of associated risk factors in HIV-1 infected Indian population.

Kamalika Mojumdar1, Madhu Vajpayee, Neeraj K Chauhan, Sanjay Mendiratta.   

Abstract

BACKGROUND: Timely access to antiretroviral therapy is a key to controlling HIV infection. Late diagnosis and presentation to care diminish the benefits of antiretrovirals and increase risk of transmission. We aimed to identify late presenters in patients sent for first CD4 T cell count after HIV diagnosis, for therapy initiation evaluation. Further we aimed at identifying patient factors associated with higher risk of late presentation.
METHODS: Retrospective data collection and analysis was done for 3680 subjects visiting the laboratory for CD4 T cell counts between 2001 and 2007. We segregated the patients on basis of their CD4 T cell counts after first HIV diagnosis. Factors associated with risk of late presentation to CD4 T cell counts after HIV diagnosis were identified using univariate analysis, and the strength of association of individual factor was assessed by calculation of odds ratios.
RESULTS: Of 3680 subjects, 2936 (83.37%) were defined as late presenters. Late testing varied among age groups, transmission categories, and gender. Males were twice as likely to present late as compared to females. We found significant positive association of heterosexual transmission route (p < 0.001), and older age groups of 45 years and above (p = 0.0004) to late presentation. Female sex, children below 14 years of age and sexual contact with HIV positive spouse were associated with significantly lower risks to presenting late. Intravenous drug users were also associated with lower risks of late presentation, in comparison to heterosexual transmission route.
CONCLUSIONS: The study identifies HIV infected population groups at a higher risk of late presentation to care and treatment. The risk factors identified to be associated with late presentation should be utilised in formulating targeted public health interventions in order to improve early HIV diagnosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20626905      PMCID: PMC2912818          DOI: 10.1186/1471-2458-10-416

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  27 in total

1.  HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?

Authors:  Dilys Morgan; Cedric Mahe; Billy Mayanja; J Martin Okongo; Rosemary Lubega; James A G Whitworth
Journal:  AIDS       Date:  2002-03-08       Impact factor: 4.177

Review 2.  Fighting against AIDS: the Brazilian experience.

Authors:  Guido Carlos Levi; Marco Antonio A Vitória
Journal:  AIDS       Date:  2002-12-06       Impact factor: 4.177

3.  Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level.

Authors:  Liselotte C van Asten; Faroudy Boufassa; Veronique Schiffer; Raymond P Brettle; J Roy Robertson; Ildefonso Hernández Aguado; Jim McMenamin; Robert Zangerle; Arnaud Fontanet; Roel A Coutinho; Maria Prins
Journal:  Eur J Public Health       Date:  2003-12       Impact factor: 3.367

4.  Factors related to delayed diagnosis of HIV infection in southeastern France. EVALVIH group.

Authors:  M Rotily; L Bentz; C Pradier; Y Obadia; P Cavailler
Journal:  Int J STD AIDS       Date:  2000-08       Impact factor: 1.359

5.  Understanding delay to medical care for HIV infection: the long-term non-presenter.

Authors:  J H Samet; K A Freedberg; J B Savetsky; L M Sullivan; M D Stein
Journal:  AIDS       Date:  2001-01-05       Impact factor: 4.177

6.  Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.

Authors:  P J Easterbrook; L M Yu; E Goetghebeur; F Boag; K McLean; B Gazzard
Journal:  AIDS       Date:  2000-03-31       Impact factor: 4.177

7.  Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.

Authors:  D D Celentano; N Galai; A K Sethi; N G Shah; S A Strathdee; D Vlahov; J E Gallant
Journal:  AIDS       Date:  2001-09-07       Impact factor: 4.177

Review 8.  Model of HIV-1 disease progression based on virus-induced lymph node homing and homing-induced apoptosis of CD4+ lymphocytes.

Authors:  D Kirschner; G F Webb; M Cloyd
Journal:  J Acquir Immune Defic Syndr       Date:  2000-08-01       Impact factor: 3.731

9.  Medical checkups: who does not get them?

Authors:  Dan Culica; James Rohrer; Marcia Ward; Peter Hilsenrath; Paul Pomrehn
Journal:  Am J Public Health       Date:  2002-01       Impact factor: 9.308

10.  Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial.

Authors:  Andrew Zolopa; Janet Andersen; William Powderly; Alejandro Sanchez; Ian Sanne; Carol Suckow; Evelyn Hogg; Lauren Komarow
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

View more
  35 in total

1.  Late presentation to HIV/AIDS testing, treatment or continued care: clarifying the use of CD4 evaluation in the consensus definition.

Authors:  S MacCarthy; D R Bangsberg; G Fink; M Reich; S Gruskin
Journal:  HIV Med       Date:  2013-09-11       Impact factor: 3.180

2.  Emotional social support and access to care among older people living with HIV in rural China.

Authors:  Chunqing Lin; Li Li; Guoping Ji; Wu Jie
Journal:  Int J Geriatr Psychiatry       Date:  2015-02-06       Impact factor: 3.485

3.  Late HIV diagnosis: Differences by rural/urban residence, Florida, 2007-2011.

Authors:  Mary Jo Trepka; Kristopher P Fennie; Diana M Sheehan; Khaleeq Lutfi; Lorene Maddox; Spencer Lieb
Journal:  AIDS Patient Care STDS       Date:  2014-03-24       Impact factor: 5.078

4.  Spectrum of AIDS Defining Opportunistic Infections in a Series of 77 Hospitalised HIV-infected Omani Patients.

Authors:  Abdullah A Balkhair; Zakariya K Al-Muharrmi; Shyam Ganguly; Ali A Al-Jabri
Journal:  Sultan Qaboos Univ Med J       Date:  2012-11-20

5.  Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa.

Authors:  Denise Evans; Simbarashe Takuva; Mohammed Rassool; Cindy Firnhaber; Mhairi Maskew
Journal:  J Neurovirol       Date:  2012-04-20       Impact factor: 2.643

6.  Immunological Response During HAART and Determinants of Current CD4+ T-Cell Count Among HIV/AIDS Patients Attending University of Gondar Referral Hospital, Northwest Ethiopia.

Authors:  Gizachew Ayele Manaye; Dejene Derseh Abateneh; Kindie Mitiku Kebede; Alemayehu Sayih Belay
Journal:  HIV AIDS (Auckl)       Date:  2020-07-31

Review 7.  The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon?

Authors:  Maria Lahuerta; Frances Ue; Susie Hoffman; Batya Elul; Sarah Gorrell Kulkarni; Yingfeng Wu; Harriet Nuwagaba-Biribonwoha; Robert H Remien; Wafaa El Sadr; Denis Nash
Journal:  J Health Care Poor Underserved       Date:  2013-02

8.  Late Presentation into Care of HIV Disease and Its Associated Factors in Asia: Results of TAHOD.

Authors:  Su Jin Jeong; Claire Italiano; Romanee Chaiwarith; Oon Tek Ng; Sasheela Vanar; Awachana Jiamsakul; Vonthanak Saphonn; Kinh Van Nguyen; Sasisopin Kiertiburanakul; Man Po Lee; Tuti Parwati Merati; Thuy Thanh Pham; Evy Yunihastuti; Rossana Ditangco; Nagalingeswaran Kumarasamy; Fujie Zhang; Wingwai Wong; Benedict L H Sim; Sanjay Pujari; Pacharee Kantipong; Praphan Phanuphak; Winai Ratanasuwan; Shinichi Oka; Mahiran Mustafa; Nicolas Durier; Jun Yong Choi
Journal:  AIDS Res Hum Retroviruses       Date:  2015-10-15       Impact factor: 2.205

9.  Correlates of Late Presentation to HIV care in a South Indian Cohort.

Authors:  Satish Rao; Satheesh Av; Bhaskaran Unnikrishnan; Deepak Madi; Avinash K Shetty
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

10.  Outcomes of antiretroviral therapy in Vietnam: results from a national evaluation.

Authors:  Duc Bui Nguyen; Nhan Thi Do; Ray W Shiraishi; Yen Ngoc Le; Quang Hong Tran; Hai Huu Nguyen; Nicholas Medland; Long Thanh Nguyen; Bruce Baird Struminger
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.